Familial atrial fibrillation as a polygenic disease with structural cardiac abnormalities: assessment of genetic risk and possibilities for gene therapy
Journal of Arrhythmology · 2023
DOI: 10.35336/va-1184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Arrhythmology, 2023. Verfasst von B. G. Iskenderov. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
The prevalence of familial atrial fibrillation (AF) in the general population and in the structure of AF is considered, and genetic predictors of AF and pathogenetic mechanisms of atrial remodeling are analyzed. The assessment of the genetic risk of AF occurrence, the prediction of its outcomes and the effectiveness of AF therapy, as well as the prospects for AF gene therapy are discussed.
Zitieren
APA
Iskenderov, B. G. (2023). Familial atrial fibrillation as a polygenic disease with structural cardiac abnormalities: assessment of genetic risk and possibilities for gene therapy. Journal of Arrhythmology. https://doi.org/10.35336/va-1184
Vancouver
Iskenderov BG. Familial atrial fibrillation as a polygenic disease with structural cardiac abnormalities: assessment of genetic risk and possibilities for gene therapy. Journal of Arrhythmology. 2023. doi:10.35336/va-1184
BibTeX
@article{Iskenderov2023,
author = {Iskenderov, B. G.},
title = {Familial atrial fibrillation as a polygenic disease with structural cardiac abnormalities: assessment of genetic risk and possibilities for gene therapy},
journal = {Journal of Arrhythmology},
year = {2023},
doi = {10.35336/va-1184}
}
EUVIMED